PharmaBoardroom

5 Tips for Success in Chinese Pharma

This is the first in a series of articles examining what it takes to be a country manager of a multinational pharma company in some of the world’s…

Company Profile: GW Pharmaceuticals

Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company with a license to cultivate cannabis…

Pierre-Claude Fumoleau – General Manager, AbbVie France

Abbvie France’s Pierre-Claude Fumoleau outlines his strategic priorities for the affiliate, AbbVie’s unique corporate culture and ethos, and how…

Hassan Behnam – Managing Director, French Chamber of…

Hassan Behnam, managing director of the French Chamber of Commerce and Industry in Egypt explains the investment opportunities Egypt has to offer,…

YJ Kim – Country Manager, BD Korea

YJ Kim, country manager at BD Korea, discusses the integration of Bard into BD at the local level. He also offers his insights into the challenges of…

Denis Delval – CEO, LFB, France

Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the new LFB. My vision is that…

Seok Joo Lee – CEO, ISU Abxis, South Korea

ISU Abxis, a subsidiary of the ISU conglomerate, is a biotech company with a focus on orphan drugs and rare disease. CEO Seok Joo Lee explains the…

Olivier Samama – General Manager, France & Head of…

Biotest’s Olivier Samama outlines the changes that the takeover of the company has had on the French affiliate, the country’s plasma market and…

The Ideal Pharma Country Manager: South Korea (DHR International)

Looking at what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. DHR…

Weidong Zhong – Founder & CEO, Terns Pharmaceuticals,…

Terns Pharmaceuticals is developing innovative drugs for the treatment of NASH and liver disease. It has established a diverse product pipeline with…

The European Medicines Verification System Launches to Tackle…

The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use cutting-edge technology to safeguard the…

Jane Griffiths – Global Head, Actelion

Jane Griffiths, global head of Actelion – acquired in 2017 by Johnson & Johnson – discusses her priorities heading up an iconic rare…

Tagged with